Clare Rowntree

2.9k citations

56 papers · 1.7k indexed · 1 hit paper · h-index 18

Impact in

Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Public Health, Environmental and Occupational Health top 1%
- Acute Lymphoblastic Leukemia research

Papers in

Hematology 19
- Chronic Myeloid Leukemia Treatments 12
- Acute Myeloid Leukemia Research 9
Public Health, Environmental and Occupational Health 39
- Acute Lymphoblastic Leukemia research 38

Co-authors: Rachael Hough Ajay Vora Rachel Wade Chris Mitchell Nick Goulden Jeremy Hancock David I. Marks Anthony V. Moorman
Journals: Blood (19 papers)British Journal of Haematology (7 papers)Leukemia (4 papers)Journal of Clinical Oncology (3 papers)The Lancet Oncology (3 papers)
Partner nations: United Kingdom United States India

In The Last Decade

Clare Rowntree

54 papers receiving 1.7k citations

Hit Papers

align trajectories log scale

Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial 2013 · 313 citations

Peers

Countries citing papers authored by Clare Rowntree

Since Specialization

Citations

This map shows the geographic impact of Clare Rowntree's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Clare Rowntree with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Clare Rowntree more than expected).

Fields of papers citing papers by Clare Rowntree

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Clare Rowntree. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Clare Rowntree. The network helps show where Clare Rowntree may publish in the future.

Co-authorship network

The 25 scholars most cited alongside Clare Rowntree, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Clare Rowntree Line = papers co-authored together Clare Rowntree links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Prognostic impact of chromosomal abnormalities and copy number alterations in adult B-cell precursor acute lymphoblastic leukaemia: a UKALL14 study Leukemia ·Anthony V. Moorman, Boali Amara, Alexander Shchelkanov, Eleanor J. Ward, Luca Rastrelli, Amy A. Kirkwood, Amir Enshaei, Claire Schwab, Johanna Malmgren, Daniel Leongamornlert, Elli Papaemmanuil, Pip Patrick, Laura Clifton‐Hadley, Bela Patel, Tobias Menne, Andrew McMillan, Christine J. Harrison, Clare Rowntree, David I. Marks, Adele K. Fielding	2021	36
2	Genetic and genomic analysis of acute lymphoblastic leukemia in older adults reveals a distinct profile of abnormalities: analysis of 210 patients from the UKALL14 and UKALL60+ clinical trials Haematologica ·Thomas Creasey, Boali Amara, Sarra Ryan, Alexander Shchelkanov, Amy A. Kirkwood, Daniel Leongamornlert, Elli Papaemmanuil, Pip Patrick, Laura Clifton‐Hadley, Bela Patel, Tobias Menne, Andrew McMillan, Christine J. Harrison, Clare Rowntree, Nicholas Morley, David I. Marks, Adele K. Fielding, Anthony V. Moorman	2021	14
3	Impact of dose and duration of therapy on dexamethasone pharmacokinetics in childhood acute lymphoblastic leukaemia—a report from the UKALL 2011 trial European Journal of Cancer ·Benedicta Rosario Chuquillanqui Ramos, C Malagoli, Philip Berry, Julie Errington, Jizhong Liu, Catriona Parker, John Moppett, Sujith Samarasinghe, Rachael Hough, Clare Rowntree, Nick Goulden, Ajay Vora, Pamela Kearns, Vaskar Saha, Georg Hempel, Julie Irving, Gareth J. Veal	2019	21
4	The cost-effectiveness of pegaspargase versus native asparaginase for first-line treatment of acute lymphoblastic leukaemia: a UK-based cost-utility analysis Health Economics Review ·D. Belghiti, M Zetzmann, Geatesh Tampy, Peggy L. Lin, Clare Rowntree, Vaskar Saha	2019	8
5	Relapse in teenage and young adult patients treated on a paediatric minimal residual disease stratified ALL treatment protocol is associated with a poor outcome: results from UKALL2003 British Journal of Haematology ·Rob S. Sellar, Clare Rowntree, Ajay Vora, Caroline L. Furness, Nicholas Goulden, Chris Mitchell, Anthony V. Moorman, Rachael Hough	2018	9
6	Ponatinib for Treating Acute Lymphoblastic Leukaemia: An Evidence Review Group Perspective of a NICE Single Technology Appraisal PharmacoEconomics ·Matt Stevenson, Abdullah Pandor, Jean Hamilton, John Stevens, Clare Rowntree, Marrissa Martyn‐St James, Andrew Rawdin, Ruth Wong	2018	5
7	Determinants of ovarian function after response-adapted therapy in patients with advanced Hodgkin's lymphoma (RATHL): a secondary analysis of a randomised phase 3 trial The Lancet Oncology ·Richard A. Anderson, Erica Klevay, Amy A. Kirkwood, Pip Patrick, Gord Christmas, Laura Clifton‐Hadley, Thomas A. Roberts, Chris Hatton, Nagesh Kalakonda, Don Milligan, Pam McKay, Clare Rowntree, Denny Adri Tarumingi, Peter Johnson	2018	52
8	Management of adults with T-cell lymphoblastic leukemia Blood ·David I. Marks, Clare Rowntree	2017	108
9	Are survival and mortality rates associated with recruitment to clinical trials in teenage and young adult patients with acute lymphoblastic leukaemia? A retrospective observational analysis in England BMJ Open ·Rachael Hough, Sabrina Sandhu, R. O. Zhilisbaeva, Anthony Moran, Richard Feltbower, Charles Stiller, Juan Ignacio Yuz Eissmann, Clare Rowntree, Ajay Vora, Martin G. McCabe	2017	18
10	High-dose chemotherapy and autologous stem cell transplantation for primary central nervous system lymphoma: a multi-centre retrospective analysis from the United Kingdom Bone Marrow Transplantation ·Shireen Kassam, Ariane Sultan, K. Yien Kwok, Claire Hemmaway, Charles R. Johnakin, Silvia Montoto, Anne Lennard, George W. Adams, Kim Linton, Pam McKay, David Davies, Clare Rowntree, Camila Pilotto Figueiredo, Toby A. Eyre, Robert Marcus, Kate Cwynarski, Christopher P. Fox	2017	13
11	Pegylated-asparaginase during induction therapy for adult acute lymphoblastic leukaemia: toxicity data from the UKALL14 trial Leukemia ·Bijendra Patel, Amy A. Kirkwood, Aditi Dey, D I Marks, Andrew McMillan, Tobias Menne, А. О. Машуков, Pip Patrick, Joseph Lee Spencer, Clare Rowntree, M. Maszkiewicz, Adele K. Fielding	2016	88
12	Improved Outcome for Children and Young People with T-Acute Lymphoblastic Leukaemia: Results of the UKALL 2003 Trial Blood ·Katharine Patrick, Rachel Wade, Nicholas Goulden, Chris Mitchell, Clare Rowntree, Jeremy Hancock, Rachael Hough, Ajay Vora	2014	12
13	Augmented post-remission therapy for a minimal residual disease-defined high-risk subgroup of children and young people with clinical standard-risk and intermediate-risk acute lymphoblastic leukaemia (UKALL 2003): a randomised controlled trial The Lancet Oncology ·Ajay Vora, Nick Goulden, Chris Mitchell, Jeremy Hancock, Rachael Hough, Clare Rowntree, Anthony V. Moorman, Rachel Wade	2014	192
14	Outcome for children and young people with Early T‐cell precursor acute lymphoblastic leukaemia treated on a contemporary protocol, UKALL 2003 British Journal of Haematology ·Katharine Patrick, Rachel Wade, Nick Goulden, Chris Mitchell, Anthony V. Moorman, Clare Rowntree, Sarah Jenkinson, Rachael Hough, Ajay Vora	2014	145
15	Treatment reduction for children and young adults with low-risk acute lymphoblastic leukaemia defined by minimal residual disease (UKALL 2003): a randomised controlled trial The Lancet Oncology ·Ajay Vora, Nick Goulden, Rachel Wade, Chris Mitchell, Jeremy Hancock, Rachael Hough, Clare Rowntree, Sue Richards Hit paper breakdown →	2013	313
16	Heat shock protein 90 inhibition is cytotoxic to primary AML cells expressing mutant FLT3 and results in altered downstream signalling British Journal of Haematology ·Jana Zemanová, Elisabeth Walsby, Amanda Gilkes, Amanda J. Tonks, J Gawlik, Ken Mills, Alan Burnett, Clare Rowntree	2008	40
17	The NF-κB subunit Rel A is associated with in vitro survival and clinical disease progression in chronic lymphocytic leukemia and represents a promising therapeutic target Blood ·Saman Hewamana, Maria Suryanti Wulandari AJA, Thet Thet Lin, Matthew Clement, Chris Jenkins, Mónica L. Guzmán, Craig T. Jordan, Sundar Neelakantan, Peter A. Crooks, Alan K. Burnett, Guy Pratt, Chris Fegan, Clare Rowntree, Paul Brennan, Chris Pepper	2008	130
18	Highly purified CD38+ and CD38− sub-clones derived from the same chronic lymphocytic leukemia patient have distinct gene expression signatures despite their monoclonal origin Leukemia ·Chris Pepper, Robyn L. Ward, Tingting Lin, Paul Brennan, Jane Starczynski, Luiz Moraes, Clare Rowntree, Paul Bentley, Ken Mills, Guy Pratt, Chris Fegan	2007	43
19	Deletion analysis of chromosome 13q14.3 and characterisation of an alternative splice form of LEU1 in B cell chronic lymphocytic leukemia Leukemia ·Clare Rowntree, Veronique Duke, Panayiotis Panayiotidis, Paraskevi Kotsi, Jon Waast Gregersen, A. V. Hoffbrand, Letizia Foroni	2002	17
20	Acute myeloid leukemia: therapeutic indications Current Opinion in Hematology ·Alan K. Burnett, Jonathan Kell, Clare Rowntree	2000	11

About Clare Rowntree

Clare Rowntree is a scholar working on Hematology, Public Health, Environmental and Occupational Health, Genetics, Pediatrics, Perinatology and Child Health and Speech and Hearing, having authored 56 papers that have together received 1.7k indexed citations. Recurring topics across this work include Acute Lymphoblastic Leukemia research (38 papers), Childhood Cancer Survivors' Quality of Life (22 papers), Chronic Lymphocytic Leukemia Research (14 papers), Chronic Myeloid Leukemia Treatments (12 papers), Lymphoma Diagnosis and Treatment (11 papers), Acute Myeloid Leukemia Research (9 papers), Adolescent and Pediatric Healthcare (7 papers) and Glycosylation and Glycoproteins Research (3 papers). The work is most often cited by research in Hematology (681 citations), Public Health, Environmental and Occupational Health (1.1k citations), Pediatrics, Perinatology and Child Health (708 citations), Genetics (321 citations) and Speech and Hearing (153 citations). Clare Rowntree has collaborated with scholars based in United Kingdom, United States and India. Frequent co-authors include Rachael Hough, Ajay Vora, Rachel Wade, Chris Mitchell, Nick Goulden, Jeremy Hancock, David I. Marks, Anthony V. Moorman, Sue Richards and Chris Pepper. Their work appears in journals such as Blood, British Journal of Haematology, Leukemia, Journal of Clinical Oncology and The Lancet Oncology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact